In the case of IRP2, the cellular iron availability signals degradation of the protein, which is, thus, only active under conditions of iron deficiency, or other conditions in which the FBXL5-dependent degradation system is inhibited [24]. This evidence concerns the gene FBXL5 and Iron deficiency anemia.